As the number of patients with Alzheimer’s
disease (AD) continues to rise throughout the twentyfirst century, scientists
are increasingly looking for remedies, although the cause and pathology of the
disease remain uncertain. Among treatments for AD, there is a renewed interest
in curcumin as a potential medication. Studies of the substance have found a
large amount of consumption associated benefits, including anti-inflammatory
and antioxidant effects. Its wide healing properties make it increasingly
interesting to scientists, with potential uses in the treatment of cancers,
arthritis, various cardiovascular diseases, and neurodegenerative diseases.
More recently, curcumin has been shown to have multipotent effects against
various symptoms of AD. Among other things, curcumin has been able to
ameliorate toxicity of beta-amyloid species, a key part of AD
nuerodegeneration, in vivo and in vitro, and has been able to inhibit multiple
parts along suspected AD pathology. The goal of this review is to summarize the
research done on curcumin with respect to its applicability as a treatment for
AD and AD related pathology.
Article by Lei Xue,from
Tongji University, Shanghai, China.
Full access: http://mrw.so/3lkE6C
 |
| Image by Marina Boyarkina,from Flickr-cc. |
评论
发表评论